Stock Events

Biomarin Pharmaceutical (BMRN) Q3 2023 Earnings

31JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.07
0.05
0.17
0.29

Details

Expected EPS
0.23
Actual EPS
0.29
Surprise EPS
0.06
Surprise Percent
+26.09%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.29 per share for Q3 2023.

0 Comments

Share your thoughts